Hyperbaric Oxygen Therapy and Diabetic Problems

  • P. Calia
  • A. Quarantiello
  • E. Faglia
  • F. Favales
  • G. Oriani
  • M. Michael


Diabetes mellitus is the most frequent among the chronic metabolic diseases, and it is characterized by hyperglycaemia as well as alterations of the lipid and protein metabolism, which are associated with the absolute or relative absence of insulinic action and/or its secretion and by long-term complications affecting various organ systems. The data of prevalence and incidence are extremely variable depending on the investigative methods used and the geographical areas considered: In fact, the total prevalence of diabetes mellitus, both insulin-dependent and non insulin-dependent, varies from less than 0.1 to more than 4% in various studies [1]. Moreover, the epidemiological data are influenced by different prevalence in the various geographical areas and in the various populations, and also by the lack of a precise codification of the diagnostic criteria of this pathology. Diagnostic criteria accepted by WHO were established in 1980 [2].


Oral Glucose Tolerance Test Diabetic Subject Autonomic Neuropathy Hyperbaric Oxygen Hyperbaric Oxygen Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    West KM (1978) Epidemiology of diabetes and its vascular lesions. Elsevier, New YorkGoogle Scholar
  2. 2.
    WHO Expert Committe on Diabetes Mellitus (1980) Second ReportWorld Health Organization. Technical Report Series 646, World Health Organization, GenevaGoogle Scholar
  3. 3.
    National Diabetes Data Group (1979) Classification and Diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1039: 19–79Google Scholar
  4. 4.
    Butterfield WJH (1964) Summary of results of the Bedford Diabetes Survey. Proc R Soc Med 57: 196PubMedGoogle Scholar
  5. 5.
    Palumbo PJ, Elverback CR, Chu CP (1976) Diabetes Melittus Incidence, survorship and cause of death in Rochester, Minnesota,1945–1970. Diabetes 26: 66Google Scholar
  6. 6.
    Prior JAM, Davidson F (1966) The Epidemiolgy of Diabetes in Polynesians and Europeans in New Zealand and the Pacific. N Z Med J 65: 375PubMedGoogle Scholar
  7. 7.
    Westlund K (1966) Incidence of diabetes mellitus in Oslo, Norway, 1925 to 1954, Report 11. Life Insurance Companies Institute for Medical Statistics: the Oslo city hospitals. Br J Prey Soc Med 3: 105Google Scholar
  8. 8.
    WHO (1965) Expert Committe Diabetes Mellitus Report. WHO Technical Reports Series No 310, WHO, GenevaGoogle Scholar
  9. 9.
    Jarrett RJ, Keen H (1975) Epidemiology of diabetes mellitus. In: Sussman KE, Metz RJ (eds) Fourth Edition Comm on Prof Ed American Diabetes AssocationGoogle Scholar
  10. 10.
    The Diabetes Control and Complication Trial Research Group (DCCT) (1993) The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986CrossRefGoogle Scholar
  11. 11.
    Garbay KH (1973) The sorbitol pathway and the complications of diabetes. N Engl J Med 288: 831–836CrossRefGoogle Scholar
  12. 12.
    Monnier VM, Vishanath V, Frank KE, Elmet CA, Danchot P, Kohn RR (1988) Relation Between complications of Type I diabetes mellitus and collagen linked fluorescence. N Engl J Med 37:456–461Google Scholar
  13. 13.
    Ziboh Va, Maruta H, Lords J, Cagle WD, Lucky W (1979) Increased biosynthesis of thromboxane in diabetic patients. Eur J Clin Invest 9: 223–228PubMedCrossRefGoogle Scholar
  14. 14.
    Wilamson JR, Tilton RG, Chang K, Kilo C (1988) Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. Diabetes Metab Rev 4:339–370CrossRefGoogle Scholar
  15. 15.
    Knowles HC Jr (1974) Magnitude of the renal failure in diabetic patients. Kidney Int 6 (Supp11): 2–10Google Scholar
  16. 16.
    Proceedings of Ophthalmology Basic and Clinical Science Course (1983) - Section 4. Retina and Vitreous Am Acad of Ophalmology. 1833 Fillmore St San Francisco, CaliforniaGoogle Scholar
  17. 17.
    Iarett RJ, Keen H, Grabaus AV (1979) The WHO multinational Study of Vascular Disease in Diabetics. 1. General descriptions. Diabetes Care 2: 175–186Google Scholar
  18. 18.
    Uusitupa M, Sitonen O, Aro O, Pyorala K (1985) Prevalence of heart coronary disease, left ventricular failure and hypertension in middle-aged newly diagnosed Type 2 (non-insulin dependent) diabetic subjects. Diabetologia 28: 22–26PubMedCrossRefGoogle Scholar
  19. 19.
    Goto J, Fukuhara M (1968) Causes of death in 933 in diabetic autopsy cases. J Jpn Diabetic Soc 1: 197Google Scholar
  20. 20.
    Langerberg et al. (1971) Diabetes Mellitus mortality in the United States 1950–1967. In: Vital and health statistics. USA Natl Center for Health Statistics 20: 1–50Google Scholar
  21. 21.
    Schade DB, Santiago IV, Rizza RA (1983) Intensive insulin therapy. Excerpta Medica, AmsterdamGoogle Scholar
  22. 22.
    WHO Study Group (1985) Diabetes Mellitus. Technical Report Series 727. World Health Organisation, GenevaGoogle Scholar
  23. 23.
    Alberti KGMM, De Fronzo RA, Keen H, Zimmet P (eds) (1992) International Textbook of Diabetes Mellitus. Wiley, New YorkGoogle Scholar
  24. 1.
    Charcot JM (1868) Sur quelques arthropaties qui paraissent dépendre d’une lésion du cerveau ou de la moelle épinière. Arch Physiol Norm Pathol, 1: 161–178Google Scholar
  25. 2.
    Fernando DIS, Connor H, Boulton AJM (1991) The diabetic foot 1990. Diabetic Med 8: 82–85PubMedCrossRefGoogle Scholar
  26. 3.
    Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328: 2676–2685CrossRefGoogle Scholar
  27. 4.
    Levin ME, O’Neal LW, Bowker JH (1993) The diabetic foot, 5th edn. Mosby-Year Book, Mosby, St. LouisGoogle Scholar
  28. 5.
    Frykberg RG (1991) The high risk foot in diabetes mellitus. Churchill Livingstone, LondonGoogle Scholar
  29. 6.
    Huse DM, Oster G (1989) The economic costs of NIDDM. JAMA 262: 2708–2713PubMedCrossRefGoogle Scholar
  30. 7.
    National Diabetes Advisory Board (1987) The national long-range plan to combat diabetes. Washington, DC, U.S. Govt. Printing Office (DHHS Publ. no. 87–1587), p 24Google Scholar
  31. 8.
    Kacy S, Wolma FJ, Flye MW (1982) Factors affecting the results of below knee amputation in patients with and without diabetes. Surg Gynecol Obstet 156: 513–518Google Scholar
  32. 9.
    Charcot JM (1991) Lower extremity amputation among persons with diabetes mellitus - Washington 1988. MMWR 40, 43, 737–739Google Scholar
  33. 10.
    Levin ME (1988) The diabetic foot: pathophysiology, evaluation and treatment. In: The diabetic foot. Levin ME., O’Neal LW (eds) Mosby, St. Louis, pp 16–17Google Scholar
  34. 11.
    Bodily KC, Burgess EM (1983) Contralateral limb and patient survival after leg amputation. Am J Surg 146: 280–282PubMedCrossRefGoogle Scholar
  35. 12.
    Mandrup-Poulsen T, Steen Jensen J (1982) Mortality after major amputation following gangrene of the lower limb. Acta Orthop Scand 53: 879–885PubMedCrossRefGoogle Scholar
  36. 13.
    Kahn O, Wagner W, Bessmann AN (1974) Mortality of diabetic patients treated surgically for lower limb infection and/or gangrene. Diabetes 23: 287–292PubMedGoogle Scholar
  37. 14.
    Silbert S (1952) Amputation of the lower extremity in diabetes mellitus: follow-up of 294 cases. Diabetes 1: 297–299PubMedGoogle Scholar
  38. 15.
    Smith D, Weinberger M, Katz B (1987) A controlled trial to increase office visits and reduce hospitalizations of diabetic patients. J Gen Intern Med 2: 232–238PubMedCrossRefGoogle Scholar
  39. 16.
    Boulton AIM, Connor H (1988) The diabetic foot 1988. Diabetic Med 5: 796–798PubMedCrossRefGoogle Scholar
  40. 17.
    Edmonds ME, Blundell MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ (1986) Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med 60: 763–771PubMedGoogle Scholar
  41. 18.
    Davidson JK,Alogna M, Goldsmith M, Borden J (1981) Assessment of program effectiveness at Grady Memorial Hospital, Atlanta. In: Educating diabetic patients. Steiner G., Lawrence P.A., (eds) Springer, Berlin Heidelberg New York, pp 329–348Google Scholar
  42. 19.
    Campbell DR (1991) In: Frykberg RG (ed) Diabetic vascular disease 3, pp 33–47. The high risk foot in diabetes mellitus. Churchill Livingstone, LondonGoogle Scholar
  43. 20.
    Reiber GE, Pecoraro RE, Koespell TD (1992) Risk factors for amputation in patients with diabetes mellitus. Ann Inter Med 117: 97–105Google Scholar
  44. 21.
    Flyn MD, Tooke JE (1992) Aetiology of diabetic foot: a role for microcirculation? Diabetic Med 9: 320–329CrossRefGoogle Scholar
  45. 22.
    Lo Gerfo FW, Coffman JD (1984) Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 311: 1615–1619CrossRefGoogle Scholar
  46. 23.
    Siperstein MD, Unger RH, Madison LL (1968) Studies of muscle capillary basement membranes in normal subjects, diabetic and prediabetic patients. J Clin Invest 47: 1973–1999PubMedCrossRefGoogle Scholar
  47. 24.
    Friederici HHR, Tucker WR, Schwartz TB (1960) Observations on small blood vessels of skin in the normal and in diabetic patients. Diabetes 15: 233–250Google Scholar
  48. 25.
    Goldenberg SG, Alex M, Joshi RA, Blumenthal HT (1959) Nonatheromatous peripheral vascular disease of the lower extremity in diabetes mellitus. Diabetes 8: 261–273PubMedGoogle Scholar
  49. 26.
    Parving HH, Rasmussen SM (1973) Transcapillary escape rate of albumin and plasma volume in short-and long-term juvenile diabetics. Scand J Clin Lab Invest, 32: 81–87CrossRefGoogle Scholar
  50. 27.
    Clavers B, Etrwiler D, Michael AF (1981) Albumin deposition in dermal capillary basement membrane in insulin-dependent diabetes mellitus: a preliminary report. Diabetes 30: 275–278CrossRefGoogle Scholar
  51. 28.
    McMillan DE (1993) The diabetic foot. In: Levin ME, O’Neal LW, Bowker JH (eds) Hemorheology, 5th edn. The diabetic foot. Mosby, St. Louis, pp 5, 115–133Google Scholar
  52. 29.
    Mathieu D, Coget JM, Wattel F (1984) Erythrocyte filterability and hyperbaric oxygen therapy. Med Sub Hyperb 3: 100–104Google Scholar
  53. 30.
    Nemiroff PM (1988) Synergistic effects of pentoxifylline and hyperbaric oxygen on skin flaps. Arch Otolaryngol Head Surg 114: 977–981CrossRefGoogle Scholar
  54. 31.
    Archer AG, Roberts VC, Watkins PJ (1984) Blood flow patterns in painful diabetic neuropathy. Diabetologia 27: 563–571PubMedCrossRefGoogle Scholar
  55. 32.
    Delbridge L, Ctercteko G, Fowler C (1985) The aetiology of diabetic neuropathic ulceration of the foot. Br J Surg 72: 1–6PubMedCrossRefGoogle Scholar
  56. 33.
    Sims DS, Cavanagh PR, Ulbrecht JS (1988) Risk factors in the diabetic foot. Phys Ther 68: 1887–1902PubMedGoogle Scholar
  57. 34.
    Ward JD (1982) The diabetic leg. Diabetologia 22: 141–147PubMedCrossRefGoogle Scholar
  58. 35.
    Ward JD, Simms JM, Knight G (1983) Venous distension in the diabetic neuropathic foot (physical sign of arteriovenous shunting). J R Soc Med 76: 1011–1013PubMedGoogle Scholar
  59. 36.
    Edmonds ME, Roberts VC, Watkins PJ (1982) Blood flow in the diabetic neuropathic foot. Diabetologia 22: 9–15PubMedCrossRefGoogle Scholar
  60. 37.
    Boulton AJM, Scarpello JHB, Ward JD (1982) Venous oxygenation in the diabetic neuropathic foot. Evidence of arteriovenous shunting ? Diabetologia 22: 6–8PubMedCrossRefGoogle Scholar
  61. 38.
    Edmonds ME, Morrison N, Lawes JW, Watkins PJ (1982) Medial arterial calcification in diabetes mellitus. Br Med J 284: 928–930CrossRefGoogle Scholar
  62. 39.
    Scarpello JHB, Martini TRP, Ward JD (1980) Ultrasound measurements of pulse-wave velocity in the peripheral arteries of diabetic subjects. Clin Sci 58: 53–57PubMedGoogle Scholar
  63. 40.
    Emanuele MA, Buchanan BJ, Abraira C (1981) Elevated leg, systolic pressure and arterial calcification in diabetic occlusive vascular disease. Diabetes Care 4, 289–292PubMedCrossRefGoogle Scholar
  64. 41.
    Barnes HB, Kaiser GC, Wilman VL (1971) Blood flow in the diabetic leg. Circulation 43: 391–394Google Scholar
  65. 42.
    Bird AD, Tefler MB (1965) Effect of hyperbaric oxygen on limb circulation. Lancet I: 355–357CrossRefGoogle Scholar
  66. 43.
    Edmonds ME, Watkins PJ (1992) The diabetic foot in Alberti KGMM, De Fronzo RA, Keen H, Zimmet P (eds) International texbook of diabetes mellitus. John Wiley, New York, pp 1537–1538Google Scholar
  67. 44.
    Spierings ECH, Saxena PR (1979) Effect of Ergotamine on cranial ateriovenous shunting in experiments with constant flow perfusion. Eur Pharmacol 56: 31–37CrossRefGoogle Scholar
  68. 45.
    Edmonds ME, Archer AG, Watkins PJ (1983) Ephedrine, a new treatment for diabetic neuropathic oedema. Lancet I: 548–551CrossRefGoogle Scholar
  69. 46.
    Letaucher C, Bardoux J, Frenaux B (1975) Les désarterialisations déedieuses dans le traitement des troubles trophiques de l’acropathie ulcero-mutilante. Nouvelle Presse Med 4: 2325–2326Google Scholar
  70. 47.
    Edmonds ME, Nicolaides KH, Watkins PJ (1986) Autonomic neuropathy and diabetic foot ulceration. Diabetic Med 3:56–59PubMedCrossRefGoogle Scholar
  71. 48.
    Hunt JA (1992) Foot infections in diabetes are rarely due to a single microorganism. Diabetic Med 9, 749–752PubMedCrossRefGoogle Scholar
  72. 49.
    Louie TJ, Bartlett JG, Tally FP, Gorbach SL (1976) Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 85: 461–463PubMedGoogle Scholar
  73. 50.
    Wallin RJ, Gubliner SH (1964) Treatment of anaerobic infections with hyperbaric oxygen. Surg Clin North Am 44: 107–112Google Scholar
  74. 51.
    Pecoraro RE (1991) The nonhealing diabetic ulcer–a major cause for limb loss. Prog Clin Biol Res 365: 27–43PubMedGoogle Scholar
  75. 52.
    Pentinnen, Niinikovski J, Kulonen E (1972) Hyperbaric oxygenation and fracture healing. A biochemical study with rats. Acta Chir Scand 138: 39–43Google Scholar
  76. 53.
    Morrey BF (1979) Hyperbaric oxygen and chronic osteomyelitis. Clin Orthop 144: 121–127PubMedGoogle Scholar
  77. 54.
    Davis JC, Neekmann JD, Delee JC, Buckwold FJ (1986) Chronic nonhematogenous osteomyelitis treated with adjuvant hyperbaric oxygen. J Bone Joint Surg 68A: 1210–1217PubMedGoogle Scholar
  78. 55.
    Baroni G, Porro T, Faglia E, Pizzi G, Mastropasqua A, Oriani G, Favales F (1987) Hyperbaric Oxygen in Diabetic Gangrene Treatment. Diabetes Care 10 (1): 81–86PubMedCrossRefGoogle Scholar
  79. 56.
    Wagner FW (1981) The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2: 64–122PubMedGoogle Scholar
  80. 57.
    Jeffcoate WJ, Macfarlane RM, Fletcher EM (1993) The description and classification of diabetic foot lesions. Diabetic Med 10: 676–679PubMedCrossRefGoogle Scholar
  81. 58.
    Ameli FM, Byrne P, Provan JL (1989) Selection of amputation level and prediction of healing using transcutaneous tissue oxygen tension (Ptc O2). J Cardiovasc Surg 30: 220–224Google Scholar
  82. 59.
    Boulton AIM (1988) The diabetic foot. Med Clin North Am 72: 1513–1530PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1996

Authors and Affiliations

  • P. Calia
    • 1
  • A. Quarantiello
    • 1
  • E. Faglia
    • 2
  • F. Favales
    • 2
  • G. Oriani
    • 3
  • M. Michael
    • 3
  1. 1.Diabetology CentreNiguarda HospitalMilanItaly
  2. 2.Diabetology CentreNiguarda HospitalMilanItaly
  3. 3.Anaesthesia, Intensive and Hyperbaric Care DepartmentGaleazzi Orthopaedic InstituteMilanItaly

Personalised recommendations